| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/19/2013 | US8399457 Pharmaceutical compounds |
| 03/19/2013 | US8399456 2,5-disubstituted arylsulfonamide CCR3 antagonists |
| 03/19/2013 | US8399453 Organic compounds |
| 03/19/2013 | US8399381 Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same |
| 03/19/2013 | CA2719531C New ruthenium complexes as catalysts for metathesis reactions |
| 03/19/2013 | CA2712783C Beta-lactamase inhibitors |
| 03/19/2013 | CA2660799C Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 03/19/2013 | CA2602444C Acetylenyl-pyrazolo-pyrimidine derivatives as mglur2 antagonists |
| 03/19/2013 | CA2562406C Cyclic amine compound |
| 03/14/2013 | WO2013036611A1 Processes and intermediates for making a jak inhibitor |
| 03/14/2013 | WO2013035827A1 Novel olefin derivative |
| 03/14/2013 | WO2013035826A1 Fused heterocyclic compound |
| 03/14/2013 | WO2013035329A1 Organic electroluminescence element |
| 03/14/2013 | WO2013034758A1 Substituted triazolopyrazines and uses thereof |
| 03/14/2013 | WO2013034755A1 Triazolopyrazine derivatives and their use for treating neurological and psychiatric disorders |
| 03/14/2013 | WO2013034570A1 Amino-substituted imidazopyridazines |
| 03/14/2013 | WO2012147092A3 Novel salts of dpp-iv inhibitor |
| 03/14/2013 | WO2012110440A9 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one derivatives their use as pde9a inhibitors |
| 03/14/2013 | WO2012025944A3 Sitagliptin, salts and polymorphs thereof |
| 03/14/2013 | US20130065913 Novel compounds |
| 03/14/2013 | US20130065901 2-aminopyridine analogs as glucokinase activators |
| 03/14/2013 | US20130065895 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 03/14/2013 | US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS |
| 03/14/2013 | US20130065893 Imidazole derivatives as aldosterone synthase inhibitors |
| 03/14/2013 | US20130065884 Anti-Infective Compounds |
| 03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
| 03/14/2013 | US20130065859 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| 03/14/2013 | DE112011101279T5 Kovalente organische Gerüste und Verfahren zu deren Herstellung Covalent organic frameworks and methods for their preparation |
| 03/14/2013 | CA2847728A1 Processes and intermediates for making a jak inhibitor |
| 03/14/2013 | CA2847514A1 Amino-substituted imidazopyridazines |
| 03/13/2013 | EP2568287A2 Modulation of chemosensory receptors and ligands associated |
| 03/13/2013 | EP2567960A2 Imidazo[1,2-a]pyrazine compounds for treatment of viral infections such as hepatitis |
| 03/13/2013 | EP2567958A1 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| 03/13/2013 | EP2566869A1 Pyridone and aza-pyridone compounds and methods of use |
| 03/13/2013 | EP2566868A1 Pyrrolo [3, 2 -d]pyrimidin-3 -yl derivatives used as activators of ampk |
| 03/13/2013 | EP2566867A1 Pyrazole compounds as jak inhibitors |
| 03/13/2013 | EP2566866A1 4 substituted pyrazolopyrimidines useful as pkc-theta inhibitors |
| 03/13/2013 | EP2566843A2 Process for the preparation of chiral beta amino carboxamide derivatives |
| 03/13/2013 | EP2566335A1 Controlled release from macromolecular conjugates |
| 03/13/2013 | EP2566333A1 Identification of stabilizers of multimeric proteins |
| 03/13/2013 | CN1938244B Fluoridation method |
| 03/13/2013 | CN102971326A Imidazopyridazinyl compounds and their uses for cancer |
| 03/13/2013 | CN102971325A Compounds for the reduction of beta-amyloid production |
| 03/13/2013 | CN102971324A MTOR selective kinase inhibitors |
| 03/13/2013 | CN102971323A Heterocyclic compounds as JANUS kinase inhibitors |
| 03/13/2013 | CN102971322A Macrocyclic compounds as TRK kinase inhibitors |
| 03/13/2013 | CN102971321A Imidazopyrazines |
| 03/13/2013 | CN102964352A Chiral 2,3-dihydropyrrole[1,2-a] indole derivatives with biological activity and asymmetric synthesizing method thereof |
| 03/13/2013 | CN102964351A Novel pharmaceutical salt of sitagliptin |
| 03/13/2013 | CN102964350A 7-hexahydropyrrolo[1, 2-a]pyrazinylquinolonecarboxylic acid derivative and its application in treatment of Helicobacter pylori infections |
| 03/13/2013 | CN102964349A Tosilate of benzodiazepine derivative, its crystal forms, their preparation method and application |
| 03/13/2013 | CN101479253B Insecticidal compounds |
| 03/13/2013 | CN101437824B Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |
| 03/13/2013 | CN101228169B Macrocyclic inhibitors of hepatitis c virus |
| 03/12/2013 | US8394843 Substituted isoindoles as glucokinase activators |
| 03/12/2013 | US8394819 Indole derivatives as CRTH2 receptor antagonists |
| 03/12/2013 | US8394786 Quinazoline derivatives |
| 03/12/2013 | CA2739422C Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes |
| 03/12/2013 | CA2699568C Azaindoles |
| 03/12/2013 | CA2697551C Piperidine derivatives as modulators of gpr119 activity |
| 03/12/2013 | CA2638573C Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions |
| 03/12/2013 | CA2566917C Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
| 03/07/2013 | WO2013033569A1 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | WO2013033515A1 Compounds and methods for assaying redox state of metabolically active cells and methods for measuring nad(p)/nad(p)h |
| 03/07/2013 | WO2013033269A1 Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same |
| 03/07/2013 | WO2013033268A2 Bivalent bromodomain ligands, and methods of using same |
| 03/07/2013 | WO2013033093A1 Heterocyclic compounds as janus kinase inhibitors |
| 03/07/2013 | WO2013032591A1 Heterocyclic compounds and uses thereof |
| 03/07/2013 | WO2013032284A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/07/2013 | WO2013031931A1 Chemokine receptor activity regulator |
| 03/07/2013 | WO2013030288A1 Substituted annellated pyrimidine and the use thereof |
| 03/07/2013 | WO2013030138A1 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | WO2013029431A1 Benzodiazepine derivatives tosylate salts, their polymorphic forms, preparation methods and uses thereof |
| 03/07/2013 | WO2013003298A3 Inhibitors of pde10 |
| 03/07/2013 | US20130060026 Processes and intermediates for making a jak inhibitor |
| 03/07/2013 | US20130059898 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 03/07/2013 | US20130059848 Cannabinoid-2 agonists |
| 03/07/2013 | US20130059847 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
| 03/07/2013 | US20130059845 Bicyclic agonists of gpr131 and uses thereof |
| 03/07/2013 | US20130059844 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 03/07/2013 | US20130059836 Pyrazolopyrimidine compounds for the treatment of cancer |
| 03/07/2013 | US20130059835 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059831 Novel crystal form of pyrrolidylthiocarbapenem derivative |
| 03/07/2013 | US20130059800 Pyrrolobenzodiazepines used to treat proliferative diseases |
| 03/07/2013 | DE102011082041A1 New substituted fused pyrimidine compounds are guanylate cyclase stimulators useful to treat and/or prevent e.g. heart failure, hypertension, ischemia, vascular disease, renal failure, thromboembolic disorders and fibrotic diseases |
| 03/07/2013 | CA2847075A1 Substituted annellated pyrimidine and the use thereof |
| 03/07/2013 | CA2846652A1 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | CA2846431A1 Heterocyclic compounds and uses thereof |
| 03/07/2013 | CA2844730A1 Pyrrolopyrazine kinase inhibitors |
| 03/06/2013 | EP2564850A1 Polo-like kinase inhibitors |
| 03/06/2013 | EP2563792A1 Imidazopyridazinyl compounds and their uses for cancer |
| 03/06/2013 | EP2563791A1 A process of a quaternary ammonium salt using phosphate |
| 03/06/2013 | EP2563790A1 A process of a quaternary ammonium salt |
| 03/06/2013 | EP2563775A1 Pyrazolyl quinazoline kinase inhibitors |
| 03/06/2013 | EP2563765A1 Bicyclic compound derivatives and their use as acc inhibitors. |
| 03/06/2013 | CN1826344B (1S, 5S)-3-(5, 6-dichloro-3-pyridinyl)-3, 6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 03/06/2013 | CN102958935A Macrocyclic integrase inhibitors |
| 03/06/2013 | CN102958934A Method for purifying fused pyrrolocarbazole derivative |
| 03/06/2013 | CN102958933A Pyrazolo [1, 5 -A] pyrimidines as antiviral agents |